Novel K-Ras G12C Switch-II Covalent Binders Destabilize Ras and Accelerate Nucleotide Exchange

Citations Over TimeTop 10% of 2018 papers

Abstract

The success of targeted covalent inhibitors in the global pharmaceutical industry has led to a resurgence of covalent drug discovery. However, covalent inhibitor design for flexible binding sites remains a difficult task due to a lack of methodological development. Here, we compared covalent docking to empirical electrophile screening against the highly dynamic target K-RasG12C. While the overall hit rate of both methods was comparable, we were able to rapidly progress a docking hit to a potent irreversible covalent binder that modifies the inactive, GDP-bound state of K-RasG12C. Hydrogen-deuterium exchange mass spectrometry was used to probe the protein dynamics of compound binding to the switch-II pocket and subsequent destabilization of the nucleotide-binding region. SOS-mediated nucleotide exchange assays showed that, contrary to prior switch-II pocket inhibitors, these new compounds appear to accelerate nucleotide exchange. This study highlights the efficiency of covalent docking as a tool for the discovery of chemically novel hits against challenging targets.

Related Papers

• → Covalent and non-covalent binding in vanadium–protein adducts(2020)23 cited
• → Covalent and non-covalent albumin binding of Au(i) bis-NHCsviapost-synthetic amide modification(2021)18 cited
• → Role of Docking in Anticancer Drug Discovery(2022)8 cited
• → Chemical Crosslinking of Myosin Subfragment-1 to F-Actin in the Presence of Nucleotide1(1984)12 cited
• → Endo-D-galacturonanase immobilized by a covalent binding to hydroxyalkyl methacrylate gels. Preparation and properties(1980)14 cited